Imbigombi OÜ
- Registry code
- 16537021
- VAT number
- EE102542505
- Address
- Harju maakond, Tallinn, Haabersti linnaosa, Kakumäe tee 226, 13516
- Registered
- 15.07.2022 · 4 yrs
- Activity
- Wholesale of pharmaceutical goods 46461
- Capital
- 2 500 €
- i•••@i•••.comLog in to see
- No tax debt
- No enforcement proceedings (12 months)
- No payment orders (12 months)
- No bankruptcy or liquidation
- No sanctions
- Report filed (2025)
- VAT registered
Board and owners
2 persons
| Board 2 | ||
|---|---|---|
| Oleg Kuzmin3 companiesno tax debt | Personal ID ↗ | 15.07.2022 |
| Victoria Abramjuk1 companyno tax debt | Personal ID ↗ | 06.07.2023 |
| Shareholders 1 | ||
| Oleg Kuzmin | 100,0% 2 500 € | 01.09.2023 |
| Beneficial owners 1 | ||
| Oleg Kuzmin3 companiesno tax debtdirect holding | 02.08.2022 | |
Business Register open data
Quarterly taxes and revenue
2026 Q2
2026 Q2. Wage is estimated from employment taxes.
| Quarter | Revenue | Change y/y | Labour taxes | State taxes | Employees |
|---|---|---|---|---|---|
| 2026 Q2 | 59 771 € | ▲ 32% | 0 € | 2 549 € | — |
| 2026 Q1 | 28 843 € | ▲ 115% | 0 € | 3 679 € | — |
| 2025 Q4 | 20 146 € | ▲ 82% | 0 € | 971 € | — |
| 2025 Q3 | 9 316 € | ▲ 14% | 648 € | 3 692 € | — |
| 2025 Q2 | 45 317 € | ▲ 1451% | 410 € | 4 035 € | 1 |
| 2025 Q1 | 13 416 € | ▲ 1292% | 0 € | 820 € | — |
| 2024 Q4 | 11 075 € | 0 € | 451 € | — | |
| 2024 Q3 | 8 200 € | ▲ 255% | 0 € | 225 € | — |
| 2024 Q2 | 2 921 € | ▼ 97% | 322 € | 580 € | — |
| 2024 Q1 | 964 € | ▼ 99% | 1 488 € | 1 395 € | — |
| 2023 Q4 | 0 € | 1 253 € | 1 180 € | 1 | |
| 2023 Q3 | 2 311 € | 1 409 € | 1 338 € | 2 |
Show full history (15 quarters)
| 2023 Q2 | 113 046 € | 1 534 € | 1 457 € | 1 | |
| 2023 Q1 | 112 340 € | 890 € | 841 € | 1 | |
| 2022 Q4 | 6 390 € | 222 € | 208 € | 1 |
Tax and Customs Board, published on the 10th of the month following the quarter. State taxes include employment taxes. CC BY-SA 3.0
Annual reports
4 yr
| 2025 | 2024 | 2023 | 2022 | ||||
|---|---|---|---|---|---|---|---|
| Sales revenue | 40 186 € | ▲ 287% | 10 379 € | ▼ 85% | 70 465 € | ▲ 817% | 7 681 € |
| Profit | -6 622 € | ▼ 76% | -3 757 € | ▲ 88% | -30 477 € | ▼ into loss | 1 109 € |
| Profit margin | -16,5% | -36,2% | -43,3% | 14,4% | |||
| Retained earnings | -33 125 € | ▼ 13% | -29 368 € | ▼ into loss | 1 109 € | 0 € | |
| Cash | 3 496 € | ▲ 152× | 23 € | ▼ 95% | 439 € | ▼ 91% | 5 156 € |
| Current assets | 40 984 € | ▲ 47% | 27 863 € | ▲ 48% | 18 809 € | ▼ 48% | 35 922 € |
| Assets | 40 984 € | ▲ 47% | 27 863 € | ▲ 48% | 18 809 € | ▼ 48% | 35 922 € |
| Current liabilities | 80 731 € | ▲ 32% | 60 988 € | ▲ 27% | 48 177 € | ▲ 38% | 34 813 € |
| Total liabilities | 80 731 € | ▲ 32% | 60 988 € | ▲ 27% | 48 177 € | ▲ 38% | 34 813 € |
| Equity | -39 747 € | ▼ 20% | -33 125 € | ▼ 13% | -29 368 € | ▼ into loss | 1 109 € |
| Labour costs | -3 492 € | ▼ 80% | -1 940 € | ▲ 89% | -17 613 € | ▼ 11× | -1 563 € |
| Employees | 1 | 0% | 1 | 0% | 1 | 0% | 1 |
| Filed | 08.07.2026 | 07.07.2025 | 29.07.2024 | 03.07.2023 | |||
| Report | In the Business Register ↗ | In the Business Register ↗ | In the Business Register ↗ | In the Business Register ↗ |
▲ growth, ▼ decline compared to the previous year (growth in liabilities is red). Business Register, annual reports. CC BY 4.0
Revenue by activity
2025
| Activity | EMTAK | Sales revenue | Osa |
|---|---|---|---|
| Wholesale of pharmaceutical goods main activity | 46461 | 40 186 € | 100% |
2025 annual report, RIK open data
Real estate
e-kinnistusraamat
Loading properties…
Source: e-kinnistusraamat (Centre of Registers and Information Systems), basic data
Debts and court cases
clean
Tax Board debtor list (daily), Official Announcements, State Gazette. The Tax Board publishes only today's list; earlier history is collected by Firmo.
Enforcement, payment orders and notices
clean
Official Announcements contain no enforcement, payment order or tax authority notices about the company.
Official Announcements (CC BY-SA 4.0). Enforcement proceedings, payment orders or tax decisions are published there only if they cannot be delivered to the company otherwise. The enforcement register is not public, so the absence of a notice does not mean there are no claims.
State: transactions, tenders, grants
none
No transactions with state agencies, procurement contracts or grants found
RTK Saldo, Riigihangete register, RTK toetatud projektid
Holdings in other companies
0
No holdings in other companies
Companies linked via the board
2
Sorted by revenue (latest report or 4 quarters).
Top 20 in activity: Wholesale of pharmaceutical goods
20
| # | Company | Revenue |
|---|---|---|
| 1 | MAGNUM MEDICAL OÜ | 295,0 m € |
| 2 | TAMRO EESTI OÜ | 239,6 m € |
| 3 | Novo Nordisk Estonia OÜ | 37,0 m € |
| 4 | SONA-PHARM OÜ | 36,9 m € |
| 5 | Boehringer Ingelheim RCV GmbH & Co KG Eesti filiaal | 30,7 m € |
| 6 | Aktsiaselts Magnum Veterinaaria | 28,6 m € |
| 7 | Osaühing Zoovetvaru | 21,5 m € |
| 8 | Osaühing Berlin-Chemie Menarini Eesti | 17,3 m € |
| 9 | Globalex Pharma OÜ | 16,1 m € |
| 10 | OÜ Micotrade | 15,8 m € |
| 11 | Apteegikaubanduse Hulgimüük OÜ | 12,2 m € |
| 12 | Aktsiaselts FORANS EESTI | 8,0 m € |
| 13 | DAAAK Pharma Int. AS | 7,6 m € |
| 14 | Gerdavit OÜ | 7,2 m € |
| 15 | AS Oribalt Tallinn | 7,0 m € |
| 16 | Aktsiaselts PAIRA | 6,2 m € |
| 17 | ORNYX OÜ | 5,1 m € |
| 18 | Pharm Origin OÜ | 5,1 m € |
| 19 | First Pharma OÜ | 4,9 m € |
| 20 | Hiirehernes OÜ | 4,8 m € |
Revenue from the latest annual report, otherwise Tax Board revenue for 4 quarters. All companies in this activity
Licences, pledges, domains
No data
History and notices
5
| Date | Type | Content |
|---|---|---|
| 01.09.2023 | Entry | Amendment entry |
| 06.07.2023 | Entry | Amendment entry |
| 03.05.2023 | Entry | Amendment entry |
| 22.02.2023 | Entry | Muutmiskanne TsMS § 595¹ lg 1 alusel |
| 15.07.2022 | Entry | First entry |